The BioNTech/Pfizer COVID-19 vaccine, 'Tozinameran', set a record by being approved for widespread use in just 337 days after the disease's identification, significantly faster than any previous vaccine. This rapid development leveraged decades of prior mRNA research and platform technology advancements.